TLR2 and acne: C. acnes is able to trigger inflammation reaction through the TLR-2 pathway and TLR-2 is highly expressed in acne lesions; therefore, this candidate peptide appears to be a new TLR-2 modulator that could be clinically tested on patients presenting inflammatory acne lesions.